Statistically significant difference was demonstrated between median MMP3 and HE4 levels among patients with low-grade ovarian cancer compared to well-differentiated ovarian cancer (G1 vs. G3) (p = 0.04 and p = 0.006, respectively) - Table 3. This evidence concerns the gene MMP3 and ovarian carcinoma.